NovoCure
NVCR · NASDAQ
Bulios Fair Price
$12.68
18.2% downside
Trenutna cena
$15.51
Po podatkih Bulios Fair Price je delnica NVCR trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
NovoCure Limited is an international biotechnology company specializing in the development of innovative therapies for cancer treatment. The company is known for its unique Tumor Treating Fields (TTFields) technology, which uses electric fields to target and treat tumors, inhibiting their growth. TTFields is a non-invasive treatment that is used for various types of cancer, including brain cancer, lung cancer, and more. NovoCure focuses on providing new therapeutic approaches that can improve treatment outcomes and the quality of life for patients suffering from cancer.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Medical - Devices
CEO
Frank Leonard
Employees
1,605
Headquarters
Baar
Prihajajoči dogodki
Earnings
Upcoming earnings report